Predictors of early progressive disease and antitumor effects by metastatic site in renal cell carcinoma treated with ipilimumab plus nivolumab.

Saved in:
Bibliographic Details
Title: Predictors of early progressive disease and antitumor effects by metastatic site in renal cell carcinoma treated with ipilimumab plus nivolumab.
Authors: Mori K; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan. morikeiichiro29@gmail.com., Yanagisawa T; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan., Kawada T; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Katayama S; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Maenosono R; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Hashimoto T; Department of Urology, Tokyo Medical University, Tokyo, Japan., Hirasawa Y; Department of Urology, Tokyo Medical University, Tokyo, Japan., Inoki L; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan., Toyoda S; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan., Nukaya T; Department of Urology, Fujita-Health University School of Medicine, Aichi, Japan., Takahara K; Department of Urology, Fujita-Health University School of Medicine, Aichi, Japan., Fukuokaya W; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan., Urabe F; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan., Iwata T; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Bekku K; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Ohno Y; Department of Urology, Tokyo Medical University, Tokyo, Japan., Shiroki R; Department of Urology, Fujita-Health University School of Medicine, Aichi, Japan., Fujita K; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan., Azuma H; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Araki M; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan.
Source: International journal of clinical oncology [Int J Clin Oncol] 2025 Nov; Vol. 30 (11), pp. 2335-2341. Date of Electronic Publication: 2025 Sep 05.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1437-7772
DOI:10.1007/s10147-025-02878-z